English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduValue & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology.”
Tag: Oncology
St. Jude Comprehensive Cancer Center receives Merit Extension Award from NCI
The St. Jude Comprehensive Cancer Center award extends its current $35 million, five-year Cancer Center Support Grant (CCSG) for an additional two years.
New Study Shows Sugar-Sweetened Drinks Increase Risk of Cancer Mortality
In a large study led by researchers at the American Cancer Society, men and women who drank two or more servings of sugar-sweetened beverages (SSB) per day, compared to people who never drank, had a five percent increased risk of death from an obesity-related cancer, including gastrointestinal, postmenopausal breast, endometrial and kidney cancer.
New Study Shows Patients Paying More Out-of-Pocket Costs for Cancer Care
A new, large study led by researchers at the American Cancer Society and The University of Texas MD Anderson Cancer Center shows rising costs of cancer treatments led to increases in total costs of care, and when compounded with greater cost sharing, increased out-of-pocket costs for privately insured, patients under 65 years old.
Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic’s Genomics Module
Ochsner Health, through its Precision Medicine Program, is the first in the nation to incorporate Epic’s Orders and Results Anywhere integration with its Genomics module.
Immunotherapy Covered in Special Edition of Current Clinical Pathology
In the latest Current Clinical Pathology publication on Immunotherapy, Sbarro Health Research Organization (SHRO) President, Antonio Giordano, M.D., Ph.D., co-edits the volume, focused on cardiovascular toxicities.
Traditional Chinese medicine reduces side effect of cancer treatment
For tens of thousands of Australians who receive radiotherapy as part of their cancer treatment, mucositis is a serious side effect that may cause inflammation, ulcers, diarrhoea, nausea and vomiting, abdominal pain and bloating. Currently there is no effective treatment for mucositis, but researchers from the University of Adelaide have found that a type of traditional Chinese medicine reduces the severity of radiation-induced gastrointestinal mucositis (GIM) in rats.
New Study Shows Two Million Life-Years Lost and $21 Billion in Lost Earnings Annually Due to Smoking Associated Cancer Deaths
A new study led by researchers at the American Cancer Society reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published today in the International Journal of Cancer.
Study Shows Fewer People Tried to Quit Smoking During COVID-19 Pandemic
A new study led by researchers at the American Cancer Society shows serious smoking cessation activity declined among adults in the United States immediately after the onset of COVID-19 and persisted for over a year. Declines in attempts to quit smoking were largest among persons experiencing disproportionately negative outcomes during COVID-19, including Black people, people with comorbidities, middle-aged people, and lower educated people. The data was published today in the Journal of the American Medical Association (JAMA) Network Open.
Hormone Replacement Therapy Doesn’t Lead to Breast Cancer Reoccurrence
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that menopausal hormone therapy for breast cancer survivors is not associated with breast cancer reoccurrence, despite worries among some researchers and physicians.
Penn Medicine Awarded $9 Million to Advance Study of Technology that Lights Up Lung Cancer Tumors
Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor tissue—helping clinicians more easily detect and remove it—the Perelman School of Medicine at the University of Pennsylvania has received a five-year, $9 million research grant from the National Cancer Institute (NCI) to push the field forward, particularly for lung cancer patients.
Study of Anti-Cancer Mitochondrial Drug Shows Additional Clinical Promise
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.
Study Shows Public Perception of E-Cigarettes vs. Cigarettes Harms Changed Sharply During EVALI Epidemic and COVID-19 Pandemic
A new study led by researchers at the American Cancer Society shows perceptions of electronic or e-cigarettes as being “more harmful” than cigarettes by adults in the United States more than doubled between 2019-2020 and perceptions of e-cigarettes as “less harmful” declined between 2018-2020.
Henry Ford Health is First in the World to Offer Latest Advancement in MR-Guided Radiation Therapy
Henry Ford Health is the first in the world to complete a full course of patient treatments using the latest advancement in magnetic resonance (MR)-guided radiation therapy, which integrates real-time magnetic resonance imaging (MRI) and linear acceleration to deliver precise and accurate radiation treatment more rapidly than ever before.
Pediatric Lymphoma Trial and Study of FLT3 Inhibitor for Leukemia Highlight Roswell Park Research at ASCO22
Researchers from Roswell Park Comprehensive Cancer Center will present the latest results of clinical trials and insights on cancer treatment and issues affecting patients with cancer, including the financial burdens induced by cancer treatment, at the annual meeting of the American Society of Clinical Oncology (ASCO), which will take place both online and in-person in Chicago, Illinois, from June 3 to 7.
CEC Oncology to Publish Four Abstracts at the 2022 ASCO Annual Meeting
CEC Oncology, the oncology arm of CE Concepts, LLC (CEC) and a subsidiary of KnowFully Learning Group, announces four abstracts accepted for publication in the Professional Development and Education Advances track of the 2022 ASCO Annual Meeting (https://conferences.asco.org/am/attend #ASCO22).
Rutgers Cancer Institute of New Jersey RWJBarnabas Health Facilities Receive First Regional Accreditation by American College of Radiology
Rutgers Cancer Institute of New Jersey Department of Radiation Oncology at Robert Wood Johnson University Hospital New Brunswick, Somerset and Hamilton, all RWJBarnabas Health facilities, received their first regional accreditation by the American College of Radiology (ACR).
Meta-Analysis Shows Targeted Radiation Therapy May Be as Effective as Standard Care for Small Cell Lung Cancer Patients with Brain Metastases
A study published in The Lancet Oncology suggests that a targeted radiation therapy is equitable to the current standard of care for patients whose lung cancer has metastasized to the brain.
New Study Finds Medicaid Expansion Increases Survival in Newly Diagnosed Cancer Patients
A new large study led by researchers at the American Cancer Society (ACS) shows Medicaid expansion under the Affordable Care Act (ACA) was associated with an increase in two-year overall survival rates among patients newly diagnosed with cancer, especially among non-Hispanic Black people and people living in rural areas.
New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand
New research led by scientists at the American Cancer Society shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States. Public interest in shopping and sales of Puff Bar skyrocketed in 2020.
New Study Shows Adolescent and Young Adult Cancer Survivors Face Increased Cancer Incidence and Mortality Risk
New findings led by researchers at the American Cancer Society (ACS) show that five-year survivors of adolescent and young adult (AYA) cancer in the United States have a higher risk of developing and nearly double the risk of dying from a new primary cancer as the general population.
Oncology specialists’ perspective on caring for patients with cancer during the early days of war in Kyiv, Ukraine
Recently, members of The Institute for Cancer Care at Mercy Medical Center oncology research team, working in conjunction with two oncologists in war-torn Ukraine, developed a report now appearing in THE LANCET/Oncology, describing the challenges faced in cancer care delivery under…
Studies Find Increase in Use of Proton Beam Therapy for Cancer Care and Increase in Racial Disparities
Two new large studies led by researchers at the American Cancer Society (ACS) show an increase in the use of proton beam therapy (PBT) for patients with cancer in the United States during the past decade.
Yale Cancer Center Study Shows Rates of PSA Testing for Prostate Cancer Increased After Revised National Guidelines
In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force on screening. The results also showed significant increases in PSA testing among older men, a group for whom screening is not routinely recommended.
CHOP-led Pediatric Hospital Network Receives Critical Government Support for Genetic Research of Pediatric Tumors
The Center for Data Driven Discovery at CHOP will procure molecular characterization for thousands of these brain tumor samples providing an unprecedented level of insight into devastating cancers and paving the way for future therapeutic interventions.
Yale Cancer Center Study Shows New Strategy to Fight Drug Resistance in HER2-Positive Breast and Ovarian Cancers
New findings by researchers at Yale Cancer Center demonstrate a novel strategy to treat tumor growth in breast and ovarian cancers characterized by HER2 gene amplification, an increase in the number of copies of a gene.
Multi-Algorithm Approach Helps Deliver Personalized Medicine for Cancer Patients
John F. McDonald and his research team have created a ‘multi-algorithm’ machine learning approach to boost accuracy in predicting drug responses for ovarian cancer patients.
Long-term survivors of childhood cancer may face higher suicide risk
Survivors of childhood cancer have increased risks of experiencing various challenges, such as emotional distress, impaired quality of life, and financial burdens.
Engineering CAR T Cells to Deliver Endogenous RNA Wakes Solid Tumors to Respond to Therapy
New study shows CAR T cells expressing RN7SL1 can activate the body’s natural immune cells against difficult-to-treat cancers
Two Studies Seek to Go Beyond the GIST of Intestinal Tract Cancer
UC San Diego researchers identify the mutational drivers for gastrointestinal stroma tumors in the stomach and find a potential drug to treat a subset of GIST tumors afflicting the young.
Sylvester Comprehensive Cancer Center Researchers Awarded Major Multi-Center Grant to Study Uveal Melanoma
Researchers at the Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine, Moffitt Cancer Center and the University of Florida Health Cancer Center received a five-year, $3.95 million NIH grant to study how uveal melanoma spreads to the liver. This work was previously supported by two Florida State Team Science Awards, which provided early-stage funding to help the team progress to the larger NIH grant.
Yale Cancer Center Perspective Highlights New Advances for NSCLC
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade.
Cancer treatment and research ‘brain gain’
Cancer patients will benefit from world-class research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).
Cancer treatment and research ‘brain gain’
Cancer patients will benefit from world-class research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).
Jersey Shore University Medical Center Now Offers Elite Regional Expertise in Orthopedic Oncology
The care of cancer (sarcomas) of the bones and soft tissues requires the expertise of a highly specialized team. Jersey Shore University Medical Center is among two of the elite Hackensack Meridian Health locations in New Jersey to offer clinical expertise in the field of orthopedic oncology.
FAU Nursing Faculty Member Receives NIH K01 Grant for Breast Cancer Research
Tarsha Jones, Ph.D., principal investigator and an assistant professor of nursing at FAU’s Christine E. Lynn College of Nursing, has received the National Institute of Health (NIH) K01 Career Development Award, a five-year, $772,525 award for a project titled, “Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors.”
John Theurer Cancer Center Selected as One of Four Beneficiaries at the 2021 Breeders Crown Charity Challenge
Hackensack Meridian John Theurer Cancer Center has been selected as one of four beneficiaries of the 2021 Breeders Crown Charity Challenge, presented by the Libfeld/Katz Breeding Partnership.
Fred Hutchinson Cancer Research Center, Seatle Children’s and UW Medicine Lay Groundwork for Historic Cancer Partnership
SEATTLE — July 13, 2021 — Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s today announced plans to explore restructuring their longtime relationship to accelerate a d mission of advancing diagnosis, treatment and pioneering of cures for cancer and other diseases.If finalized and approved, the proposed restructure would establish an adult-focused oncology program and, separately, a pediatric oncology program.
NCCN Maintains Qualification as CMS-Approved Provider-Led Entity for the Development of Imaging Appropriate Use Criteria
NCCN, an alliance of 31 leading cancer centers, has again qualified as a provider-led entity (PLE) for the Medicare Appropriate Use Criteria (AUC) Program by Centers for Medicare & Medicaid Services (CMS), the nation’s largest health payer.
CAP Releases Updates to Cancer Protocols, Essential for Cancer Reporting and Patient Care
The College of American Pathologists (CAP) released updates to the CAP Cancer Protocols, clinical guidance for reporting pathologic features in the treatment of cancer patients.
Researchers engineer ‘natural killer’ cells that attack and destroy malignant tumour cells but leave the rest alone
Researchers at McMaster University have developed a promising new cancer immunotherapy that uses cancer-killing cells genetically engineered outside the body to find and destroy malignant tumours.
Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Blood cancer patients with COVID-19 fare better with convalescent plasma
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma — the pale yellow liquid in blood that is rich in antibodies — from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.
Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Surgeon and reproductive scientist Patricia Kilroy Donahoe, MD, FACS, named recipient of 2021 Jacobson Innovation Award
One of the world’s most influential reproductive scientists, Patricia Kilroy Donahoe, MD, FACS, will receive the 2021 Jacobson Innovation Award of the American College of Surgeons (ACS) during a virtual event to be held in her honor this evening.
Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer
A study led by researchers at Yale Cancer Center, Stony Brook University and KDx Diagnostics, Inc., examined a revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker, and revealed the test can detect the presence of new bladder cancer in patients with hematuria, or blood in the urine.
John Theurer Cancer Center investigators report new findings at American Society of Clinical Oncology 2021 Annual Meeting
Innovative research refines the treatment of patients with advanced cancers and the use of immunotherapy
Inflammation and Procalcitonin Predict Success, or Not, of Lung Cancer Treatment
In patients with non-small cell Lung Cancer (NSCLC), the presence of either high chronic inflammation, or procalcitonin levels in the blood as a response to bacterial infection, both predict a poor response to treatment with immune checkpoint blockade.
Rare Case of Lactic Acidosis Associated with Small Lymphocytic Lymphoma (SLL) in Elderly Man Published in Journal of Cancer Research and Oncobiology
A team of researchers from Hackensack Meridian Jersey Shore University Medical Center and the Cleveland Clinic, led by Professor of Medicine and Nephrologist Sushil K. Mehandru, M.D., authored a new report.
Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income. The results were published online today in the Journal of Clinical Oncology (JCO).